Page last updated: 2024-10-26

racemetirosine and Carditis

racemetirosine has been researched along with Carditis in 1 studies

alpha-Methyltyrosine: An inhibitor of the enzyme TYROSINE 3-MONOOXYGENASE, and consequently of the synthesis of catecholamines. It is used to control the symptoms of excessive sympathetic stimulation in patients with PHEOCHROMOCYTOMA. (Martindale, The Extra Pharmacopoeia, 30th ed)

Research Excerpts

ExcerptRelevanceReference
"The latest evidence suggests that cytokine storm syndrome (CSS) is an important cause of the transition from mild to critical pneumonia and critically ill patients' death."2.66Cytokine storms caused by novel coronavirus 2019 and treatment for cardiac injury. ( Chen, SL; Zhang, DM, 2020)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Zhang, DM1
Chen, SL1

Reviews

1 review available for racemetirosine and Carditis

ArticleYear
Cytokine storms caused by novel coronavirus 2019 and treatment for cardiac injury.
    European review for medical and pharmacological sciences, 2020, Volume: 24, Issue:23

    Topics: alpha-Methyltyrosine; Angiotensin-Converting Enzyme 2; Antibodies, Monoclonal, Humanized; Antioxidan

2020